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Introduction 
Human growth hormone (hGH) is secreted 
from the anterior pituitary gland and exerts a 
wide variety of functions such as, IGF-1 
production, protein synthesis, glucose 
metabolism, lipolysis, lipogenesis, and cell 
proliferation/differentiation (Isaksson et al., 
1985; Press, 1988; Thorner and Vance, 1988; 
Strobl and Thomas, 1994). Moreover, 
recently, hGH has attract much interest from 
scientists because it is found to not only retard 
biological aging, but also to significantly 
reverse many of the effects of aging (Klatz 
and Kahn, 1998). Besides 22K-hGH (22,000 
Dalton), which is a major component 
composed of 191 amino acids, 20K-hGH 
(20,000 Dalton) is also known to be naturally 
secreted, being encoded by the same gene as 
22K-hGH and lacking 15 amino acids 
(residues 32–46) by alternative messenger 
RNA (mRNA) splicing (DeNoto et al., 1981; 
Lewis, et al., 1980).  
The methylotrophic yeast, Pichia pastoris 
has become the second most important yeast 
expression system after S. cerevisiae. P. 
pastoris has been developed as an expression 
system for high-level production of 
recombinant proteins (Buckholz & Gleeson, 
1991; Cregg et al., 1993). Pichia offers the 
features of (i) methanol-induced expression of 
heterologous genes via integration of the gene 
into the genome adjacent to the alcohol 
oxidase I (AOX1) gene promoter, (ii) growth 
to high cell density in inexpensive, chemically 
defined media, and (iii) the capacity to carry 
out post-translational modifications 
resembling those of mammalian cells (Cregg 
et al., 1993; Romanos, 1995). Due to the 
absence of stable episomal vector in Pichia, 
recombinant plasmid has to be recombined 
into Pichia chromosome via gene conversion 
or integration events, thus generating two 
types of methanol utilization phenotype 
(Romanos, 1995). Integration of recombinant  
 
plasmid at his4 or AOX1 locus will revealed 
methanol utilization plus (Mut+) phenotype in 
GS115 and SMD1168 strains; on the other 
hand, replacement of AOX1 locus via gene 
conversion will generate methanol utilization 
slow (MutS) phenotype in GS115 and 
SMD1168 strains. 
In this report, we describe the construction 
of synthetic hGH gene and the expression of 
recombinant hGH in Pichia strains GS115 and 
SMD1168 via shake-flask culture. 
 
Methods and materials 
 
Human growth hormone (hGH) gene 
construction 
The synthetic hGH gene was constructed 
using single-step assembly polymerase chain 
technique derived from DNA shuffling 
(Stemmer, 1994; Stemmer et al., 1995). 
Twenty hGH oligonucleotides (Alpha DNA, 
Canada), each about 54 nucleotides in length, 
which collectively encode both strands of 
hGH gene were designed. The BamHI and 
EcoRI sites were introduced at the 5’-end 
and 3’-end of hGH gene, respectively for 
the directional cloning into the P. pastoris 
expression vector, pPIC3.5K (Invitrogen, CA, 
USA). Apart from that, the Kozak consensus 
sequence 5’-GCCACCATG-3’ has been 
appended at the 5’-end downstream of the 
BamHI site as initiation of translation. In this 
research project, P. pastoris GS115 and 
SMD1168 (Invitrogen, USA) were used as the 
expression hosts; thus, the oligos were 
designed with the consideration of P. pastoris 
codon usage.  
The PCR product amplified by Taq DNA 
polymerase was purified using Qiagen 
QIAquickTM Gel Extraction kit and was 
ligated into the pGEM®-T vector (Promega). 
Subsequently, the recombinant plasmid was 
transformed into E. coli JM109 according to 
the standard procedure described in Sambrook 
et al. (1989). The plasmid extracted was then 
subjected to sequencing using ABI PRISM® 
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BigDyeTM Terminator Cycle Sequencing 
Ready Reaction kit (PE Biosystem) for 
nucleotide sequence confirmation. 
 
Mutagenesis of synthetic hGH gene 
Among four clones, where the recombinant 
plasmids have been verified by sequencing, 
the fourth clone’s plasmid showed the most 
promising result with six mutations along the 
612 bp hGH gene. The mutations comprised 
of a base insertion, base deletion at two 
locations, and base misincorporation at three 
different locations. Stratagene QuikChange® 
site-directed mutagenesis kit was used to 
repair the frame-shift and point mutations 
found in the DNA fragment. Thus, six pairs of 
PAGE purified mutagenic oligonucleotide 
primers (Alpha DNA, Canada), each about 45 
nucleotides in length, were designed 
according to the protocol provided in the 
Stratagene QuikChange® site-directed 
mutagenesis instruction manual for the repair 
of six mutations at different locations. 
  
Sequencing and cloning 
Prior to sequencing for confirmation, the 
mutagenized recombinant plasmids were 
extracted using Promega Wizard® Plus SV 
Minipreps DNA Purification System. After 
sequencing, the recombinant plasmids were 
digested with EcoRI and BamHI restriction 
enzymes to obtain the synthetic human growth 
hormone DNA fragment. The digested hGH 
DNA fragment was purified from ethidium 
bromide stained agarose gel using QIAquick® 
Gel Extraction Kit (QIAGEN) and ligated into 
P. pastoris expression vector, pPIC3.5K using 
T4 DNA ligase (Promega). pPIC3.5K (9004 
bp) is an intracellular expression vector 
containing a strong alcohol oxidase 1 (AOX 
1) promoter, which could be induced by 
methanol for high-level protein expression. 
 
Transformation and selection of P. pastoris 
clones 
P. pastoris strains GS115 (his4) and 
SMD1168 (his4 pep4) were used for 
expression of the hGH protein. Cell culture, 
electro-competent cells, transformation and 
selection of recombinant clones were 
performed as described in the Pichia User 
Manual (Invitrogen, USA). Prior to 
transformation, recombinant pPIC3.5K vector 
containing synthetic hGH gene was linearized 
using BspEI restriction enzyme (New England 
Biolabs). 20 µg of purified BspEI-linearized 
recombinant plasmid was used in the 
electroporation transformation. Electroporated 
cells were plated on a dextrose-base 
regeneration medium lacking histidine (RDB) 
and incubated for 3 days at 30°C for histidine 
prototrophy screening. Randomly picked 
clones were subculture and lysed prior to 
direct PCR screening using 5’-AOX1 and 3’-
AOX1 primers for methanol utilization (Mut) 
phenotype. 
 
Induction of expression in shake-flask 
culture 
Each of recombinant GS115 and 
SMD1168 His+ Mut+ clones were picked and 
subjected to expression in shake-flask culture 
according to method described in Pichia User 
Manual (Invitrogen, USA). Time course study 
of 0-120 h with interval duration of 24 h was 
carried out to determine the optimal protein 
expression time point, mean while, 100% 
methanol was added daily to a final 
concentration of 3% until induction was 
terminated. 
 
SDS-PAGE and Western blots 
SDS-PAGE according to a modified 
version of Laemmli’s method (Laemmli, 
1970) and Western blot analysis according to 
Towbin et al. (1979) were performed for 
recombinant hGH analysis. Bands were 
visualized using horseradish peroxidase-
conjugated donkey anti-goat IgG antibody 
(Promega) and the ECL Western blotting kit 
(Amersham Pharmacia Biotech). The primary 
antibody used was goat polyclonal anti-hGH 
antibody (Santa Cruz Biotechnology, Inc.). 50 
µg of total protein was analysed in 12.5% 
(v/v) SDS-PAGE following by western blot. 
 
Results and discussion 
We have sequenced four clones for the 
hGH DNA fragment amplified by Taq DNA 
Polymerase. The results showed that 20 
oligonucleotides have been assembled 
accordingly. However, there were a few 
insertion, deletion and misincorporation of 
bases, which might be due to improper 
purification of the oligonucleotides. Hence, 
solution for reducing mutations in the 
synthetic gene is to use highly purified 
oligonucleotides containing no (n-1) failure 
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sequence. The mutations were successfully 
repaired using Stratagene QuikChange® site-
directed mutagenesis kit. We have also 
successfully cloned the synthetic human 
growth hormone gene into Pichia expression 
vector. 
By linearizing the recombinant vector at a 
restriction enzyme site located in HIS4 gene, 
using BspEI enzyme, Mut+ recombinants were 
conveniently generated either in GS115 or 
SMD1168 strains via single crossover 
integration event. GS115/pPIC3.5K-hGH 
[2/5] and SMD1168/pPIC3.5K [30] were His+ 
Mut+ recombinant clones randomly picked for 
protein expression. Direct PCR using both 
recombinant clones’ cell lysates showed two 
bands on 1.2% (w/v) agarose gel. The ~2.2 kb 
band and the ~800 bp band correspond to the 
AOX1 gene in Pichia genome and the 
synthetic hGH gene, respectively. The 
presence of AOX1 gene indicates that the 
recombinant clones were Mut+. The PCR 
results showed that the synthetic hGH gene 
was integrated into the genome of 
recombinant P. pastoris, which proved that 
recombinant P. pastoris had excellent genetic 
stability in terms of the properties of growth 
and expression of recombinant hGH protein. 
A total protein of 50 µg of each cell lysate 
samples, including the corresponding 
expression condition control strain GS115 β-
gal (Mut+) were analysed on 12.5% (v/v)  
SDS-PAGE. Recombinant hGH was not 
detected on 12.5% (v/v) SDS gel when 
compared to the background control, which 
was the expression product of GS115 strain 
transformed with parent vector. Nevertheless, 
the expression condition control, β-
galactosidase of GS115 β-gal (Mut+) control 
strain was successfully expressed as detected 
on the gel at 117 kDa, which indicates that the 
expression condition was efficient.  
Western blot analysis of the cell lysates 
showed that the recombinant hGH was 
successfully expressed in both recombinant 
clones, GS115/pPIC3.5K-hGH [2/5] and 
SMD1168/pPIC3.5K [30]. Two bands with 
the size of ~22 kDa and ~20 kDa were present 
on the X-ray film. The expected size of 
recombinant hGH is 22 kDa and the ~20 kDa 
product obtained could be the non-22 kDa 
growth hormone isoform (Wood, 2001). No 
reaction was detected over the lanes 
containing total protein at non-induction time 
point (0 h) for both of the recombinant strains; 
strongly indicate that the binding of the 
recombinant protein by goat anti-hGH was 
significant and specific. Time course study 
was carried out to determine the optimal time 
post-induction to harvest. Nevertheless, no 
significant increase of protein expression level 
was observed for both recombinant clones 
after 24 h (Figure 1.1 and Figure 1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.1 Immunodetection (Western blot) 
of recombinant hGH protein expressed in 
recombinant clone GS115/pPIC3.5K-hGH [2/5] 
using polyclonal goat anti-hGH. Lane (1), 
Rainbow protein molecular weight markers 
(Amersham Pharmacia Biotech); lane (2)-(7), time 
course study with an interval time of 24 h (from 0-
120 h) of recombinant GS115/ pPIC3.5K-hGH 
[2/5]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.2 Immunodetection (Western blot) 
of recombinant hGH protein expressed in 
recombinant clone SMD1168/pPIC3.5K-hGH [30] 
using polyclonal goat anti-hGH. Lane (1), 
Rainbow protein molecular weight markers 
(Amersham Pharmacia Biotech); lane (2)-(7), time 
course study with an interval time of 24 h (from 0-
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120 h) of recombinant SMD1168/pPIC3.5K-hGH 
[30].  
In summary, the results obtained in 
Western blotting revealed that the 
recombinant hGH protein is expressed stably 
in P. pastoris in shake-flask culture. Further 
study will be carried out to increase the 
protein expression level and to purify the 
recombinant protein for biological activity 
analysis, as well as to verify the presence of 
non-22 kDa hGH isoforms in the results 
obtained. 
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